Yes. Thanks, John. As Mike mentioned in his opening remarks, our exceptional financial results, underscore the team's strong execution, deep relationships with our suppliers and customers and strong demand for our technologies. It was an outstanding quarter, where we delivered strong top line growth and record profitability. For the trailing 12-month period, our non-GAAP EPS was $4.01 and our adjusted EBITDA totaled $163 million. Both are company records and highlight our consistent strong financial performance. We achieved 18% adjusted ROIC for Q3, as we balanced our working capital investments to support our growth and meet future demand. Q3 net sales of $846 million, up 16% year-over-year, reflects strong customer demand across our technologies and a modest benefit from supplier price increases. Additionally, Q3 benefited by approximately $30 million of sales pulled forward from Q4, due to timing of product availability near the end of the quarter. Intelisys net sales increased 18% year-over-year and includes the benefit of timing and supplier commissions. Our gross profit grew 21% year-over-year to $107 million. Our Q3 margins increased to 12.6%, up from 12.1% in the prior year's quarter and includes a onetime benefit from supplier price increases of approximately 45 basis points. Our non-GAAP SG&A expense for the quarter of $66.5 million, increased $6.7 million or 11% year-over-year. This includes people and IT investments ahead of revenues, primarily in our Modern Communications & Cloud segment. Our Q3 results include approximately $3 million of onetime SG&A expense benefits, primarily due to a large bad debt recovery in the quarter. Third quarter adjusted EBITDA totaled $44.1 million, up 38% year-over-year, reflecting a 5.21% adjusted EBITDA margin, which includes the benefit of the onetime items we've discussed. For fiscal year 2022, we estimate the effective tax rate, excluding discrete items to range from 25.5% to 26.5%. Now, turning to the balance sheet and cash flow. We generated operating cash of $30 million for the quarter and $16 million for the trailing 12 months. Year-over-year working capital which includes accounts receivable and inventory net of accounts payable, increased $80 million or 18% year-over-year to support our sales growth. Q3 DSO of 69 days increased quarter-over-quarter and year-over-year. This increase is primarily driven by sales timing concentration at the end of the quarter, adding approximately four days to our reported DSO. On March 31, 2022, we had cash and cash equivalents of $44 million and debt of $182 million. Our balance sheet remains very strong. From a net debt leverage perspective, we ended Q3 at approximately 0.8 times trailing 12 months adjusted EBITDA, demonstrating financial flexibility to support our growth and create long-term value. During the March quarter, we had approximately $8.3 million in share repurchases under our $100 million share repurchase authorization. As Mike noted in his opening remarks, we are raising our FY 2022 net sales growth and adjusted EBITDA expectations and our updated guidance includes the benefits of the onetime items noted in the quarter. We'll now open it up for questions.